November 3, 2015 / 2:36 PM / 2 years ago

BUZZ-Valeant Pharmaceuticals International Inc: Set to continue gain

** Canadian drugmaker’s U.S.-listed shares up 5.1 pct at $105.55 premarket

** Shares set to continue gain for second straight day

** On Monday, short-seller Citron Research said it was taking a back seat in investigating Valeant, but not backing down from earlier allegations (bit.ly/1Q1YY2b)

** Stock closed up 7 pct on Monday

** Up to Monday’s close, Valeant’s stock had tumbled nearly 31.5 pct since Oct. 21, when Citron said the Canadian company was using specialty pharmacies to inflate revenue

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below